Copyright Reports & Markets. All rights reserved.

Global Veterinary Combination Vaccine and Multivalent Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Combination Vaccine
    • 1.3.3 Multivalent Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Domestic Animal
    • 1.4.3 Poultry
  • 1.5 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size & Forecast
    • 1.5.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Boehringer Ingelheim
    • 2.1.1 Boehringer Ingelheim Details
    • 2.1.2 Boehringer Ingelheim Major Business
    • 2.1.3 Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.1.4 Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.2 Zoetis
    • 2.2.1 Zoetis Details
    • 2.2.2 Zoetis Major Business
    • 2.2.3 Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.2.4 Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Zoetis Recent Developments/Updates
  • 2.3 Merck Animal Health
    • 2.3.1 Merck Animal Health Details
    • 2.3.2 Merck Animal Health Major Business
    • 2.3.3 Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.3.4 Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck Animal Health Recent Developments/Updates
  • 2.4 HIPRA
    • 2.4.1 HIPRA Details
    • 2.4.2 HIPRA Major Business
    • 2.4.3 HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.4.4 HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 HIPRA Recent Developments/Updates
  • 2.5 Ceva Animal Health
    • 2.5.1 Ceva Animal Health Details
    • 2.5.2 Ceva Animal Health Major Business
    • 2.5.3 Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.5.4 Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Ceva Animal Health Recent Developments/Updates
  • 2.6 Bioveta
    • 2.6.1 Bioveta Details
    • 2.6.2 Bioveta Major Business
    • 2.6.3 Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.6.4 Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bioveta Recent Developments/Updates
  • 2.7 Elanco
    • 2.7.1 Elanco Details
    • 2.7.2 Elanco Major Business
    • 2.7.3 Elanco Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.7.4 Elanco Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Elanco Recent Developments/Updates
  • 2.8 Virbac
    • 2.8.1 Virbac Details
    • 2.8.2 Virbac Major Business
    • 2.8.3 Virbac Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.8.4 Virbac Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Virbac Recent Developments/Updates
  • 2.9 Pulike Biological
    • 2.9.1 Pulike Biological Details
    • 2.9.2 Pulike Biological Major Business
    • 2.9.3 Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.9.4 Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Pulike Biological Recent Developments/Updates
  • 2.10 Ringpu Bio-technology
    • 2.10.1 Ringpu Bio-technology Details
    • 2.10.2 Ringpu Bio-technology Major Business
    • 2.10.3 Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.10.4 Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Ringpu Bio-technology Recent Developments/Updates
  • 2.11 China Animal Husbandy Industry
    • 2.11.1 China Animal Husbandy Industry Details
    • 2.11.2 China Animal Husbandy Industry Major Business
    • 2.11.3 China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.11.4 China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 China Animal Husbandy Industry Recent Developments/Updates
  • 2.12 Keqian Biology
    • 2.12.1 Keqian Biology Details
    • 2.12.2 Keqian Biology Major Business
    • 2.12.3 Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.12.4 Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Keqian Biology Recent Developments/Updates
  • 2.13 Aichong Group
    • 2.13.1 Aichong Group Details
    • 2.13.2 Aichong Group Major Business
    • 2.13.3 Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.13.4 Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Aichong Group Recent Developments/Updates
  • 2.14 Yian Biological
    • 2.14.1 Yian Biological Details
    • 2.14.2 Yian Biological Major Business
    • 2.14.3 Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.14.4 Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Yian Biological Recent Developments/Updates
  • 2.15 Harbin Pharmaceutical Group
    • 2.15.1 Harbin Pharmaceutical Group Details
    • 2.15.2 Harbin Pharmaceutical Group Major Business
    • 2.15.3 Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.15.4 Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Harbin Pharmaceutical Group Recent Developments/Updates
  • 2.16 Bolaideli Biotechnology
    • 2.16.1 Bolaideli Biotechnology Details
    • 2.16.2 Bolaideli Biotechnology Major Business
    • 2.16.3 Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.16.4 Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Bolaideli Biotechnology Recent Developments/Updates
  • 2.17 Huapai Biotechnology
    • 2.17.1 Huapai Biotechnology Details
    • 2.17.2 Huapai Biotechnology Major Business
    • 2.17.3 Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product and Services
    • 2.17.4 Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Huapai Biotechnology Recent Developments/Updates

3 Competitive Environment: Veterinary Combination Vaccine and Multivalent Vaccine by Manufacturer

  • 3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Veterinary Combination Vaccine and Multivalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Veterinary Combination Vaccine and Multivalent Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Veterinary Combination Vaccine and Multivalent Vaccine Manufacturer Market Share in 2025
  • 3.5 Veterinary Combination Vaccine and Multivalent Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Veterinary Combination Vaccine and Multivalent Vaccine Market: Region Footprint
    • 3.5.2 Veterinary Combination Vaccine and Multivalent Vaccine Market: Company Product Type Footprint
    • 3.5.3 Veterinary Combination Vaccine and Multivalent Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Region
    • 4.1.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value (2021-2032)
  • 4.5 South America Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country
    • 7.3.1 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country
    • 8.3.1 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country
    • 10.3.1 South America Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Veterinary Combination Vaccine and Multivalent Vaccine Market Drivers
  • 12.2 Veterinary Combination Vaccine and Multivalent Vaccine Market Restraints
  • 12.3 Veterinary Combination Vaccine and Multivalent Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Veterinary Combination Vaccine and Multivalent Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Veterinary Combination Vaccine and Multivalent Vaccine
  • 13.3 Veterinary Combination Vaccine and Multivalent Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Veterinary Combination Vaccine and Multivalent Vaccine Typical Distributors
  • 14.3 Veterinary Combination Vaccine and Multivalent Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Veterinary Combination Vaccine and Multivalent Vaccine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Veterinary Combination Vaccine and Multivalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Veterinary Combination Vaccine and Multivalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Veterinary Combination Vaccine and Multivalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Veterinary Combination Vaccine and Multivalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Veterinary Combination Vaccine and Multivalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Dose), and ASP (US$/Dose), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Veterinary Combination Vaccine and Multivalent Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Veterinary Combination Vaccine and Multivalent Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Zoetis, Merck Animal Health, HIPRA, Ceva Animal Health, Bioveta, Elanco, Virbac, Pulike Biological, Ringpu Bio-technology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Veterinary Combination Vaccine and Multivalent Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Combination Vaccine
    Multivalent Vaccine
    Market segment by Application
    Domestic Animal
    Poultry
    Major players covered
    Boehringer Ingelheim
    Zoetis
    Merck Animal Health
    HIPRA
    Ceva Animal Health
    Bioveta
    Elanco
    Virbac
    Pulike Biological
    Ringpu Bio-technology
    China Animal Husbandy Industry
    Keqian Biology
    Aichong Group
    Yian Biological
    Harbin Pharmaceutical Group
    Bolaideli Biotechnology
    Huapai Biotechnology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Veterinary Combination Vaccine and Multivalent Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Veterinary Combination Vaccine and Multivalent Vaccine, with price, sales quantity, revenue, and global market share of Veterinary Combination Vaccine and Multivalent Vaccine from 2021 to 2026.
    Chapter 3, the Veterinary Combination Vaccine and Multivalent Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Veterinary Combination Vaccine and Multivalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Veterinary Combination Vaccine and Multivalent Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Combination Vaccine and Multivalent Vaccine.
    Chapter 14 and 15, to describe Veterinary Combination Vaccine and Multivalent Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now